Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research 05 2018
- 2100-2109 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-17-2855 doi
Antineoplastic Combined Chemotherapy Protocols--adverse effects Biomarkers--blood Carcinoma, Non-Small-Cell Lung--blood Chromatography, Liquid Computational Biology Female Humans Lung Neoplasms--blood Male Metabolome Metabolomics--methods Prognosis ROC Curve Reproducibility of Results Tandem Mass Spectrometry Treatment Outcome Workflow